Jim Simons Renaissance Technologies
Jim Simons is the founder of Renaissance Technologies, one of the most successful quantitative hedge funds in the world. Before his career in finance, he served as a mathematics professor and made significant contributions to differential geometry. Simons applied his analytical expertise to develop sophisticated, algorithm-driven trading strategies, earning consistently high returns for investors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Zoom
ZM
|
+$806M |
| 2 |
AbbVie
ABBV
|
+$481M |
| 3 |
T-Mobile US
TMUS
|
+$464M |
| 4 |
Kroger
KR
|
+$430M |
| 5 |
Baidu
BIDU
|
+$423M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$1.35B |
| 2 |
AGN
Allergan plc
AGN
|
+$1.26B |
| 3 |
S
Sprint Corporation
S
|
+$675M |
| 4 |
Amgen
AMGN
|
+$488M |
| 5 |
Humana
HUM
|
+$450M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 23.76% |
| 2 | Technology | 16.41% |
| 3 | Consumer Staples | 10.58% |
| 4 | Consumer Discretionary | 10.13% |
| 5 | Communication Services | 9.97% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1501
AudioCodes
AUDC
$255M
| $6.25M | 0.01% |
+196,526
| New | +$6.04M |
|
1502
Signet Jewelers
SIG
$3.52B
| $6.25M | 0.01% |
608,300
-1,149,810
| -65% | -$11.4M |
|
1503
Ziff Davis
ZD
$1.89B
| $6.25M | 0.01% |
113,620
-15,410
| -12% | -$1.01M |
|
|
SHYF
1504
DELISTED
The Shyft Group
SHYF
| $6.24M | 0.01% |
370,648
-195,452
| -35% | -$2.95M |
|
|
JOBS
1505
DELISTED
51job Inc
JOBS
| $6.23M | 0.01% |
86,800
+13,488
| +18% | +$885K |
|
1506
Bridgewater Bancshares
BWB
$619M
| $6.23M | 0.01% |
607,367
+28,520
| +5% | +$276K |
|
|
KIN
1507
DELISTED
Kindred Biosciences, Inc.
KIN
| $6.22M | 0.01% |
1,384,509
+201,611
| +17% | +$901K |
|
1508
EPR Properties
EPR
$4.71B
| $6.19M | 0.01% |
186,900
-69,600
| -27% | -$2.07M |
|
|
HNGR
1509
DELISTED
Hanger Inc.
HNGR
| $6.18M | 0.01% |
373,106
-13,756
| -4% | -$232K |
|
1510
Digital Turbine
APPS
$1.52B
| $6.17M | 0.01% |
490,700
-48,000
| -9% | -$335K |
|
1511
Seneca Foods Class A
SENEA
$1.29B
| $6.17M | 0.01% |
182,363
+29,500
| +19% | +$1.04M |
|
|
PCSB
1512
DELISTED
PCSB Financial Corporation
PCSB
| $6.16M | 0.01% |
485,682
+23,200
| +5% | +$302K |
|
1513
Schwab US Aggregate Bond ETF
SCHZ
$10.5B
| $6.15M | 0.01% |
218,600
+140,400
| +180% | +$3.91M |
|
|
KDMN
1514
DELISTED
Kadmon Holdings, Inc.
KDMN
| $6.14M | 0.01% |
+1,199,100
| New | +$5.38M |
|
1515
Pearson
PSO
$9.73B
| $6.09M | 0.01% |
841,800
+218,200
| +35% | +$1.36M |
|
1516
Franklin Covey
FC
$225M
| $6.08M | 0.01% |
284,203
-49,800
| -15% | -$1.01M |
|
1517
Groupon
GRPN
$867M
| $6.08M | 0.01% |
+335,453
| New | +$7.47M |
|
|
CHUY
1518
DELISTED
Chuy's Holdings, Inc. Common Stock
CHUY
| $6.06M | 0.01% |
407,500
+36,200
| +10% | +$542K |
|
1519
Visteon
VC
$2.88B
| $6.05M | 0.01% |
88,400
+60,900
| +221% | +$3.83M |
|
|
MGIC
1520
DELISTED
Magic Software Enterprises
MGIC
| $6.05M | 0.01% |
535,665
-12,300
| -2% | -$121K |
|
1521
Pediatrix Medical
MD
$2.17B
| $6.05M | 0.01% |
353,900
-129,511
| -27% | -$1.92M |
|
1522
Hawkins
HWKN
$2.74B
| $6.03M | 0.01% |
283,198
+67,600
| +31% | +$1.28M |
|
1523
Janus Henderson Short Duration Income ETF
VNLA
$3.36B
| $6.02M | 0.01% |
+119,771
| New | +$5.97M |
|
1524
Wyndham Hotels & Resorts
WH
$5.46B
| $6M | 0.01% |
+140,900
| New | +$5.75M |
|
1525
National CineMedia
NCMI
$262M
| $5.98M | 0.01% |
201,289
+44,620
| +28% | +$1.34M |
|
Similar funds
Jim Simons's Q2 2020 Portfolio in Review
As of Q2 2020, Jim Simons held 3,987 positions worth $116B, up 13% from $103B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
Jim Simons withdrew a net $8.24B in Q2 2020, closing 596 positions and reducing 1,366 holdings. Its most notable exit was Allergan plc, an estimated $1.26B position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 24% of assets, down from 26% a quarter earlier, followed by Technology and Consumer Staples.
Against the trend, Jim Simons opened a new position in Uber worth $187M.
- Jim Simons's largest Q2 2020 buy was Uber: 6,030,316 shares worth $187M.
- Jim Simons added most to Zoom in Q2 2020, an estimated $806M increase.
- Jim Simons's biggest Q2 2020 reduction was Bristol-Myers Squibb, cutting an estimated $1.35B.
- Jim Simons fully exited Allergan plc in Q2 2020, selling an estimated $1.26B.
- Jim Simons's ten largest holdings make up 14% of its $116B portfolio in Q2 2020.
- Jim Simons opened 584 new positions and closed 596 in Q2 2020.
- Jim Simons's portfolio value rose 13% quarter-over-quarter to $116B.
Based on Renaissance Technologies's 13F filing for Q2 2020, filed 13 Aug 2020.